Anzeige
Mehr »
Montag, 17.11.2025 - Börsentäglich über 12.000 News
Die KI-Comeback-Story des Jahres 2025
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3DL7T | ISIN: SE0017769995 | Ticker-Symbol: BGLA
Tradegate
14.11.25 | 20:09
9,535 Euro
0,00 % 0,000
1-Jahres-Chart
BIOGAIA AB Chart 1 Jahr
5-Tage-Chart
BIOGAIA AB 5-Tage-Chart
RealtimeGeldBriefZeit
9,5259,54516.11.
9,5309,53514.11.

Aktuelle News zur BIOGAIA Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
Leser Medien
28.10.BioGaia AB and University of Gothenburg discovered a new role for bacteria present in the gut: serotonin production202Often considered as our "second brain", the human gut and its resident microbiota play a crucial bidirectional role communicating the brain (central nervous system) with the gut (enteric nervous system)...
► Artikel lesen
22.10.BioGaia AB: Interim Management Statement January - September 2025101THIRD QUARTER 2025 Net sales amounted to SEK 326.6 million (304.0), an increase of SEK 22.7 million, or an increase of 7% (excluding foreign exchange effects an increase of 14%). Net sales in the...
► Artikel lesen
16.10.The study on BioGaia's new patented strain L. reuteri BG-R46 published in Beneficial Microbes3
13.10.Invitation to media and analyst briefing for BioGaia Q3 2025 report3
BIOGAIA Aktie jetzt für 0€ handeln
30.09.BioGaia launches Prodentis FRESH BREATH, a probiotic promoting instant and long-lasting fresh breath while supporting healthy gums and teeth2
10.09.BioGaia AB establishes its own distribution in Germany and Austria202BioGaia AB (NASDAQ: BIOG) establishes its own distribution in Germany and Austria through a newly formed subsidiary in Germany which will distribute and market BioGaia's products in both Germany and...
► Artikel lesen
01.09.BioGaia's probiotic can help prevent antibiotic-associated diarrhea in children2
27.08.Shares purchased by BioGaia's Chairman Mauricio Graber3
22.08.Extraordinary General Meeting of BioGaia3
25.07.Notice to attend the Extraordinary General Meeting of BioGaia AB (publ)2
18.07.BioGaia AB: Interim Report January - June 2025227SECOND QUARTER 2025 Net sales amounted to SEK 404.7 million (384.1), an increase of SEK 20.6 million, or an increase of 5% (excluding foreign exchange effects an increase of 13.2%). Net sales in the...
► Artikel lesen
16.07.BioGaia AB launches a subsidiary company - BioGaia New Sciences AB - dedicated to advancing microbiome research and innovation319As interest in biotics1 and their wide range of health applications continues to grow, BioGaia is proud to announce the launch of a subsidiary company, BioGaia New Sciences AB, dedicated to exploring...
► Artikel lesen
09.07.BioGaia AB's Nomination Committee for the 2026 Annual General Meeting 1
08.07.Invitation to media and analyst briefing for BioGaia Q2 2025 report3
30.05.Change in the number of votes in BioGaia AB (publ)1
08.05.Dividendenbekanntmachungen (08.05.2025)12.405 Unternehmen  ISIN-Code  Dividende (Währung)  Dividende (EUR)  ADDNODE GROUP AB  SE0017885767  1,15 SEK  0,1052 EUR  AG BARR PLC  GB00B6XZKY75  0,1376 GBP  0,1617 EUR  ALANTRA PARTNERS SA  ES0126501131 - 0...
► Artikel lesen
07.05.BioGaia AB: Interim Management Statement January - March 2025317FIRST QUARTER 2025 Net sales amounted to SEK 366.3 million (369.8), a decrease of SEK 3.5 million, or a decrease of 1% (excluding foreign exchange effects a decrease of 3.6%). Net sales in the Pediatrics...
► Artikel lesen
20.03.BioGaia AB: Transition in BioGaia: Anatom Holding, a Switzerland-based long-term investment firm, becomes anchor shareholder382BioGaia AB (NASDAQ: BIOG) announces that Annwall & Rothschild Investments AB (owned by Jan Annwall and BioGaia's Chairman Peter Rothschild), another member of the Rothschild family and David Dangoor...
► Artikel lesen
12.02.BioGaia AB: Year-end report January - December 2024269FOURTH QUARTER 2024 (Figures in parentheses refer to the corresponding period last year, unless otherwise specified). Net sales amounted to SEK 364.8 million (297.8), an increase of SEK 67.1 million...
► Artikel lesen
04.02.BioGaia AB: BioGaia's results for the fourth quarter to exceed market expectations260(Figures in the brackets refer to the same period the previous year) During the fourth quarter of 2024, BioGaia reports growth across all regions with stronger performance in Americas and stronger...
► Artikel lesen
20 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1